Floatz logo

Semaglutide

PCOS

Methodist Health Systemprotein_peptidePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
95/ 100

Competitive context

65 Active assets in the PCOS cohort.

Asset / SponsorPhaseRating
Liraglutide
Peking University Third Hospital
Phase 4BBB
Hcg
Eman Basuni Ebrahim Mowad
Phase 4BBB
Drospirenone
Ege University
Phase 4BBB
FOLLITROPIN BETA
Universitair Ziekenhuis Brussel
Phase 4BBB
Glucophage
Near East University, Turkey
Phase 4BBB

View all 50 →

Same molecule, other indications

Semaglutide is also rated in:

metabolic diseaseDormant
A
Indicative ·
81 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
prediabetes syndromeDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →